Role of Env in resistance of feline immunodeficiency virus (FIV)-infected cats to superinfection by a second FIV strain as determined by using a chimeric virus

Journal of Virology

Volumn 81, Issue 19, 2007, Pages 10474-10485

  Giannecchini, Simone ^a,b   Pistello, Mauro ^a   Isola, Patrizia ^a   Matteucci, Donatella ^a   Mazzetti, Paola ^a   Freer, Giulia ^a   Bendinelli, Mauro ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAT; CELL GROWTH; CHIMERA; CONTROLLED STUDY; FELINE IMMUNODEFICIENCY VIRUS; FEMALE; GENETIC CODE; LENTIVIRINAE; LYMPHOID CELL; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; SUPERINFECTION; VIRUS ENVELOPE; VIRUS GENOME; VIRUS INFECTION; VIRUS NEUTRALIZATION; VIRUS RESISTANCE; VIRUS STRAIN;

ANIMALS; BASE SEQUENCE; CATS; CHIMERA; DNA, VIRAL; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; GENE PRODUCTS, REV; GENES, ENV; IMMUNODEFICIENCY VIRUS, FELINE; LYMPHOID TISSUE; MOLECULAR SEQUENCE DATA; RNA, VIRAL;

ANIMALIA; CERCOPITHECINE HERPESVIRUS 1; FELINE IMMUNODEFICIENCY VIRUS; LENTIVIRUS;

EID: 34648816166     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01064-07     Document Type: Article

References (55)

1. Altfeld, M., T. M. Allen, X. G. Yu, M. N. Johnston, D. Agrawal, B. T. Korber, D. C. Montefiori, D. H. O'Connor, B. T. Davis, P. K. Lee, E. L. Maier, J. Harlow, P. J. Goulder, C. Brander, E. S. Rosenberg, and B. D. Walker. 2002. HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus. Nature 420:434-439.
2. + T helper cells in the cytotoxic T lymphocyte response to HIV-1. Curr. Opin. Immunol. 12:375-380.
3. Bendinelli, M., M. Pistello, D. Del Mauro, G. Cammarota, F. Maggi, A. Leonildi, S. Giannecchini, C. Bergamini, and D. Matteucci. 2001. During readaptation in vivo, a tissue culture-adapted strain of feline immunodeficiency virus reverts to broad neutralization resistance at different times in individual hosts but through changes at the same position of the surface glycoprotein. J. Virol. 75:4584-4593.
4. Broche-Pierre, S., J. Richardson, A. Moraillon, and P. Sonigo. 2005. Evaluation of live feline immunodeficiency virus vaccines with modified antigenic properties. J. Gen. Virol. 86:2495-2506.
5. Burkhard, M. J., and G. A. Dean. 2003. Transmission and immunopathogenesis of FIV in cats as a model for HIV. Curr. HIV Res. 1:15-29.
6. Burkhard, M. J., C. K. Mathiason, K. O'Halloran, and E. A. Hoover. 2002. Kinetics of early FIV infection in cats exposed via the vaginal versus intravenous route. AIDS Res. Hum. Retrovir. 18:217-226.
7. Burton, D. R., R. C. Desrosiers, R. W. Doms, W. C. Koff, P. D. Kwong, J. P. Moore, G. J. Nabel, J. Sodroski, I. A. Wilson, and R. T. Wyatt. 2004. HIV vaccine design and the neutralizing antibody problem. Nat. Immunol. 5:233-236.
8. Cheonis, N. 2006. Dual HIV infection. BETA 18:36-40.
9. Chohan, B., L. Lavreys, S. M. J. Rainwater, and J. Overbaugh. 2005. Evidence for frequent reinfection with human immunodeficiency virus type 1 of a different subtype. J. Virol. 79:10701-10708.
10. Connor, R., D. Montefiori, J. Binley, J. Moore, S. Bonhoeffer, A. Gettie, E. Fenamore, K. Sheridan, D. Ho, P. Dailey, and P. Marx. 1998. Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine. J. Virol. 72:7501-7509.
11. Daniel, M. D., F. Kirchhoff, S. C. Czajak, P. K. Sehgal, and R. C. Desrosiers. 1992. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258:1938-1941.
12. Del Mauro, D., D. Matteucci, S. Giannecchini, F. Maggi, M. Pistello, and M. Bendinelli. 1998. Autologous and heterologous neutralization analyses of primary feline immunodeficiency virus isolates. J. Virol. 72:2199-2207.
13. Desrosiers, R. C., J. D. Lifson, J. S. Gibbs, S. C. Czajak, A. Y. Howe, L. O. Arthur, and R. P. Johnson. 1998. Identification of highly attenuated mutants of simian immunodeficiency virus. J. Virol. 72:1431-1437.
14. Dunham, S., and O. Jarrett. 2006. FIV as a model for AIDS vaccine studies, p. 293-332. In H. Friedman, M. Bendinelli, and S. Specter (ed.), Animal models of HIV infection and control, Springer, New York, NY.
15. Dunham, S. P., J. Bruce, D. Klein, J. N. Flynn, M. C. Gelder, S. MacDonald, O. Jarrett, and J. C. Neil. 2006. Prime-boost vaccination using DNA and whole inactivated virus vaccines provides limited protection against virulent feline immunodeficiency virus. Vaccine 24:7095-7108.
16. Elder, J. H., G. A. Dean, E. A. Hoover, J. A. Hoxie, M. H. Malim, L. Mathes, J. C. Neil, T. W. North, E. E. Sparger, M. B. Tompkins, W. A. Tompkins, J. Yamamoto, N. Yuhki, N. C. Pedersen, and R. H. Miller. 1998. Lessons from the cat: feline immunodeficiency virus as a tool to develop intervention strategies against human immunodeficiency virus type 1. AIDS Res. Hum. Retrovir. 14:797-801.
17. Friedman, H., M. Bendinelli, and S. Specter (ed.). 2006. Animal models of HIV infection and control, p. 436. Springer, New York, NY.
18. Fultz, P. N., A. Srinivasan, C. R. Greene, D. Butler, R. B. Swenson, and H. M. McClure. 1987. Superinfection of a chimpanzee with a second strain of human immunodeficiency virus. J. Virol. 61:4026-4029.
19. Giannecchini, S., D. Del Mauro, D. Matteucci, and M. Bendinelli. 2001. AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: reevaluation of neutralizing antibody levels elicited by a protective and a nonprotective vaccine after removal of antisubstrate cell antibodies. J. Virol. 75:4424-4429.
20. Gundlach, B. R., S. Reiprich, S. Sopper, R. E. Means, U. Dittmer, K. Matz-Rensing, C. Stahl-Hennig, and K. Uberla. 1998. Env-independent protection induced by live, attenuated simian immunodeficiency virus vaccines. J. Virol. 72:7846-7851.
21. Heeney, J. L. 2004. Requirement of diverse T-helper responses elicited by HIV vaccines: induction of highly targeted humoral and CTL responses. Exp. Rev. Vaccines 3:S53-S64.
22. Heeney, J. L., and S. A. Plotkin. 2006. Immunological correlates of protection from HIV infection and disease. Nat. Immunol. 7:1281-1284.
23. Hosie, M. J., and J. A. Beatty. 2007. Vaccine protection against feline immunodeficiency virus: setting the challenge. Aust. Vet. J. 85:5-12.
24. Hosie, M. J., and J. N. Flynn. 1996. Feline immunodeficiency virus vaccination: characterization of the immune correlates of protection. J. Virol. 70:7561-7568.
25. Hosie, M. J., B. J. Willett, D. Klein, T. H. Dunsford, C. Cannon, M. Shimojima, J. C. Neil, and O. Jarrett. 2002. Evolution of replication efficiency following infection with a molecularly cloned feline immunodeficiency virus of low virulence. J. Virol. 76:6062-6072.
26. Hu, D. J., S. Subbarao, S. Vanichseni, P. A. Mock, A. Ramos, L. Nguyen, T. Chaowanachan, F. van Griensven, K. Choopanya, T. D. Mastro, and J. W. Tappero. 2005. Frequency of HIV-1 dual subtype infections, including intersubtype superinfections, among injection drug users in Bangkok, Thailand. AIDS 19:303-308.
27. Johnson, R. P. 2002. Mechanisms of protection against simian immunodeficiency virus infection. Vaccine 20:1985-1987.
28. Jost, S., M. C. Bernard, L. Kaiser, S. Yerly, B. Hirschel, A. Samri, B. Autran, L. E. Goh, and L. Perrin. 2002. A patient with HIV-1 superinfection. N. Engl. J. Med. 347:731-736.
29. Kalams, S. A., and B. D. Walker. 1998. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses. J. Exp. Med. 188: 2199-2204.
30. Khatissian, E., V. Monceaux, M. C. Cumont, M. P. Kieny, A. M. Aubertin, and B. Hurtrel. 2001. Persistence of pathogenic challenge virus in macaques protected by simian immunodeficiency virus SIVmacΔnef. J. Virol. 75:1507-1515.
31. Kiepiela, P., K. Ngumbela, C. Thobakgale, D. Ramduth, I. Honeyborne, E. Moodley, S. Reddy, C. de Pierres, Z. Mncube, N. Mkhwanazi, K. Bishop, M. van der Stok, K. Nair, N. Khan, H. Crawford, R. Payne, A. Leslie, J. Prado, A. Prendergast, J. Frater, N. McCarthy, C. Brander, G. H. Learn, D. Nickle, C. Rousseau, H. Coovadia, J. I. Mullins, D. Heckerman, B. D. Walker, and P. Goulder. 2007. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat. Med. 13:46-53.
32. Koff, W. C., P. R. Johnson, D. I. Watkins, D. R. Burton, J. D. Lifson, K. J. Hasnkrug, A. B. McDermott, A. Schultz, T. J. Zamb, R. Boyle, and R. C. Desrosiers. 2006. HIV vaccine design: insights from live attenuated SIV vaccines. Nat. Immunol. 7:19-23.
33. Letvin, N. J., D. H. Barouch, and D. C. Montefiori. 2002. Prospects for vaccine protection against HIV-1 infection and AIDS. Annu. Rev. Immunol. 20:73-99.
34. Letvin, N. L., Y. Huang, B. K. Chakrabarti, L. Xu, M. S. Seaman, K. Beaudry, B. Korioth-Schmitz, F. Yu, D. Rohne, K. L. Martin, A. Miura, W. P. Kong, Z. Y. Yang, R. S. Gelman, O. G. Golubeva, D. C. Montefiori, J. R. Mascola, and G. J. Nabel. 2004. Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys. J. Virol. 78:7490-7497.
35. Lombardi, S., C. Garzelli, C. La Rosa, L. Zaccaro, S. Specter, G. Malvaldi, F. Tozzini, and M. Bendinelli. 1993. Identification of a linear neutralization site within the third variable region of the feline immunodeficiency virus envelope. J. Virol. 67:4742-4749.
36. Matteucci, D., M. Pistello, P. Mazzetti, S. Giannecchini, D. Del Mauro, I. Lonetti, L. Zaccaro, C. Pollera, S. Specter, and M. Bendinelli. 1997. Studies of AIDS vaccination using an ex vivo feline immunodeficiency virus model: protection conferred by a fixed cell vaccine against cell-free and cell-associated challenge differs in duration and is not easily boosted. J. Virol. 71:8368-8376.
37. McMichael, A. J. 2006. HIV vaccines. Annu. Rev. Immunol. 24:227-255.
38. Mills, J., R. Desrosiers, E. Rud, and N. Almond. 2000. Live attenuated HIV vaccines: a proposal for further research and development. AIDS Res. Hum. Retrovir. 16:1453-1461.
39. Obert, L. A., and E. A. Hoover. 2000. Relationship of lymphoid lesions to disease course in mucosal feline immunodeficiency virus type C infection. Vet. Pathol. 37:386-401.
40. Obert, L. A., and E. A. Hoover. 2002. Early pathogenesis of transmucosal feline immunodeficiency virus infection. J. Virol. 76:6311-6322.
41. Otten, R. A., D. L. Ellenberger, D. R. Adams, C. A. Fridlund, E. Jackson, D. Pieniazek, and M. A. Rayfield. 1999. Identification of a window period for susceptibility to dual infection with two distinct human immunodeficiency virus type 2 isolates in a Macaca nemestrina (pig-tailed macaque) model. J. Infect. Dis. 180:673-684.
42. Pedersen, N. C., E. W. Ho, M. L. Brown, and J. K. Yamamoto. 1987. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 235:790-793.
43. Pistello, M., F. Bonci, P. Isola, P. Mazzetti, A. Merico, L. Zaccaro, D. Matteucci, and M. Bendinelli. 2005. Evaluation of feline immunodeficiency virus ORF-A mutants as candidate attenuated vaccine. Virology 332:676-690.
44. Pistello, M., D. Matteucci, F. Bonci, P. Isola, P. Mazzetti, L. Zaccaro, A. Merico, D. Del Mauro, N. Flynn, and M. Bendinelli. 2003. AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: protection from an intraclade challenge administered systemically or mucosally by an attenuated vaccine. J. Virol. 77:10740-10750.
45. Pistello, M., D. Matteucci, G. Cammarota, P. Mazzetti, S. Giannecchini, D. Del Mauro, S. Macchi, L. Zaccaro, and M. Bendinelli. 1999. Kinetics of replication of a partially attenuated virus and of the challenge virus during a three-year intersubtype feline immunodeficiency virus superinfection experiment in cats. J. Virol. 73:1518-1527.
46. Ramos, A., D. J. Hu, L. Nguyen, K.-O. Phan, S. Vanichseni, N. Promadej, K. Choopanya, M. Callahan, N. L. Young, J. McNicholl, T. D. Mastro, T. M. Folks, and S. Subbarao. 2002. Intersubtype human immunodeficiency virus type 1 superinfection following seroconversion to primary infection in two injection drug users. J. Virol. 76:7444-7452.
47. Shibata, R., C. Siemon, M. W. Cho, L. O. Arthur, S. M. Nigida, Jr., T. Matthews, L. A. Sawyer, A. Schultz, K. K. Murthy, Z. Israel, A. Javadian, P. Frost, R. C. Kennedy, H. C. Lane, and M. A. Martin. 1996. Resistance of previously infected chimpanzees to successive challenges with a heterologous intraclade B strain of human immunodeficiency virus type 1. J. Virol. 70:4361-4369.
48. Siebelink, K. H., W. Huisman, J. A. Karlas, G. F. Rimmelzwaan, M. L. Bosch, and A. D. M. E. Osterhaus. 1995. Neutralization of feline immunodeficiency virus by polyclonal feline antibody: simultaneous involvement of hypervariable regions 4 and 5 of the surface glycoprotein. J. Virol. 69:5124-5127.
49. Siebelink, K. H., G. F. Rimmelzwaan, M. L. Bosch, R. H. Meloen, and A. D. M. E. Osterhaus. 1993. A single amino acid substitution in hypervariable region 5 of the envelope protein of feline immunodeficiency virus allows escape from virus neutralization. J. Virol. 67:2202-2208.
50. Smith, D. M., D. D. Richman, and S. J. Little. 2005. HIV superinfection. J. Infect. Dis. 192:438-444.
51. Sparger, E. E. 2006. FIV as a model for HIV: an overview, p. 149-237. In H. Friedman, M. Bendinelli, and S. Specter (ed.), Animal models of HIV infection and control. Springer, New York, NY.
52. + lymphocytes do not mediate protection against acute superinfection 20 days after vaccination with a live attenuated simian immunodeficiency virus. J. Virol. 79:12264-12272.
53. Talbott, R. L., E. E. Sparger, K. M. Lovelace, W. M. Fitch, N. C. Pedersen, P. A. Luciw, and J. H. Elder. 1989. Nucleotide sequence and genomic organization of feline immunodeficiency virus. Proc. Natl. Acad. Sci. USA 86:5743-5747.
54. Vahlenkamp, T. W., M. B. Tompkins, and W. A. F. Tompkins. 2006: FIV as a model for AIDS pathogenesis studies, p. 239-273. In Friedman, H., M. Bendinelli, and S. Specter (ed.), Animal models of HIV infection and control. Springer, New York, NY.
55. Wyand, M. S., K. Manson, D. C. Montefiori, J. D. Lifson, R. P. Johnson, and R. C. Desrosiers. 1999. Protection by live, attenuated simian immunodeficiency virus against heterologous challenge. J. Virol. 73:8356-8363.